The total body LMI of OI type III was significantly lower than that of OI type IV patients (P<0.05), and trunk/limb fat mass ratio of the COL1A2 mutant group was higher than COL1A1 mutant group (P<0.05, Figure 2). This evidence concerns the gene COL1A2 and osteogenesis imperfecta type 4.